selective publication antidepressant trials influence apparent efficacy pubmed ncbi abstract background evidence-based medicine valuable extent evidence base complete unbiased selective publication clinical trials--and outcomes trials--can lead unrealistic estimates drug effectiveness alter apparent risk-benefit ratio methods obtained reviews food drug administration fda studies num antidepressant agents involving num patients conducted systematic literature search identify matching publications trials reported literature compared published outcomes fda outcomes compared effect size derived published reports effect size derived entire fda data set results num fda-registered studies num accounting num study participants published studies published study outcome total num studies viewed fda positive results published num study viewed positive published studies viewed fda negative questionable results num exceptions published num studies published opinion conveyed positive outcome num studies published literature appeared num trials conducted positive contrast fda analysis showed num positive separate meta-analyses fda journal data sets showed increase effect size ranged num num individual drugs num conclusions determine bias observed resulted failure submit manuscripts part authors sponsors decisions journal editors reviewers publish selective reporting clinical trial results adverse consequences researchers study participants health care professionals patients copyright num massachusetts medical society 
